Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease

被引：0
|
作者：
Carugno, Andrea [1 ,2 ]
Brigenti, Noemi [3 ]
Gisondi, Paolo [3 ]
Al Ghadban, Zeina [4 ]
Parietti, Michele [1 ]
Vezzoli, Pamela [1 ]
Sena, Paolo [1 ]
Pisciotta, Chiara [5 ]
机构：
[1] ASST Papa Giovanni XXIII, Dermatol Unit, Piazza OMS 1, Bergamo, Italy
[2] Univ Milano Bicocca, PhD Program Mol & Translat Med DIMET, Milan, Italy
[3] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy
[4] Univ Milano Bicocca, Sch Med & Surg SMS, Milan, Italy
[5] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Milan, Italy
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2023年 / 64卷 / 04期
关键词：
Charcot-Marie-Tooth; demyelinating neurological disorders; interleukin (IL)-23; psoriasis; risankizumab;
D O I：
10.1111/ajd.14154
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：e376 / e378
页数：3
相关论文
共 38 条
  • [21] Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study
    Costanza Pazzaglia
    F. Camerota
    M. Germanotta
    E. Di Sipio
    C. Celletti
    L. Padua
    Journal of Neurology, 2016, 263 : 1434 - 1441
  • [22] Report of a Patient with Multiple Mutations Leading to Charcot-Marie-Tooth Disease and Distal Spinal Muscular Atrophy: A Case Report
    Mehrabi, Atefeh
    Farhud, Dariush D.
    Nayernia, Karim
    Sadighi, Hossein
    Zarif-Yeganeh, Marjan
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (03) : 588 - 592
  • [23] Treatment-induced remission of medulloblastoma using a chemotherapeutic regimen devoid of vincristine in a child with Charcot-Marie-Tooth disease
    Bernstock, J. D.
    Cohen, J. L.
    Singh, S.
    Schlappi, C. W.
    Fiveash, J. B.
    Johnston, J. M.
    Fequiere, P.
    Orr, B. A.
    Li, R.
    Friedman, G. K.
    CURRENT ONCOLOGY, 2019, 26 (02) : E266 - E269
  • [24] Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study
    Ibba, Luciano
    Gargiulo, Luigi
    Alfano, Angela
    Ingurgio, Ruggero Cascio
    Costanzo, Antonio
    Valenti, Mario
    Narcisi, Alessandra
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [25] Safety and Efficacy of Anti-IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis A Randomized Clinical Trial
    Li, Xiaojiao
    Li, Bing
    Yang, Deming
    Wang, Meng
    Li, Qianqian
    Wang, Nan
    Fang, Min
    Liu, Jingrui
    Zhang, Hong
    Wu, Min
    Li, Cuiyun
    Zhu, Xiaoxue
    Ding, Yanhua
    Li, Shanshan
    JAMA DERMATOLOGY, 2025, 161 (03) : 247 - 255
  • [26] Clinical, electrophysiological and pathological findings in a patient with Charcot-Marie-Tooth disease 4D caused by the NDRG1 Lom mutation
    Luigetti, Marco
    Taroni, Franco
    Milani, Micaela
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 345 (1-2) : 271 - 273
  • [27] Targeted exomes reveal simultaneous MFN2 and GDAP1 mutations in a severe Charcot-Marie-Tooth disease type 2 phenotype
    Anghelescu, C.
    Francou, B.
    Cardas, R.
    Guiochon-Mantel, A.
    Aubourg, P.
    Servais, L.
    Gidaro, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (03) : E15 - E16
  • [28] Electrical storm in a patient with Charcot-Marie-Tooth disease treated with radiofrequency ablation and subsequent serious complication of implantable cardioverter defibrillator implantation: a case report
    Vrtal, Jiri
    Plasek, Jiri
    Vaclavik, Jan
    Sipula, David
    Dodulik, Jozef
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2025, 9 (01)
  • [29] Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review
    Blauvelt, Andrew
    Chiricozzi, Andrea
    Ehst, Benjamin D.
    Lebwohl, Mark G.
    ADVANCES IN THERAPY, 2023, 40 (08) : 3410 - 3433
  • [30] Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review
    Andrew Blauvelt
    Andrea Chiricozzi
    Benjamin D. Ehst
    Mark G. Lebwohl
    Advances in Therapy, 2023, 40 : 3410 - 3433
1234